Divi's Laboratories (DIVISLAB) — Board Meeting

Divi's Laboratories announced its 35th AGM on August 11, 2025, via video conference, where shareholders will vote on adopting FY2024-25 financials, declaring a ₹30 per share dividend (1500% on ₹2 face value) payable from August 16, and approving a 400% remuneration hike for director Nimmagadda Venkata Anirudh to ₹4 lakhs monthly effective September 1. The board also reappointed Ms. Nilima Prasad Divi and Dr. S. Devendra Rao, with the latter joining as a whole-time manufacturing director. Shareholders must register emails with Kfin Technologies by August 4 to e-vote remotely via NSDL or CDSL platforms, with voting open from August 7 to 10.

📄 View Original Announcement (PDF)

📊 Stock Analysis — DIVISLAB ✨ Ask AI About This

About Divi's Laboratories Limited (DIVISLAB)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,79,470.03 Cr P/E: 72.4 ROE: 16.6% ROCE: 22.1%

View full DIVISLAB stock details →

📡 Get AI alerts when DIVISLAB files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track DIVISLAB — Free

💡 Ask AI about this filing

"How does this board meeting affect Divi's Laboratories Limited's outlook?" "What did Divi's Laboratories Limited announce on 14 July 2025?" "Is this positive or negative for DIVISLAB?"

Ask AI Free →

📊 More DIVISLAB filings

See all DIVISLAB filings →

🔥 Also filed on 14 July 2025

HCLTECH HCL Technologies Limited Corporate Action HCLTECH HCL Technologies Limited Financial Results SRF SRF Limited Announcement TCS Tata Consultancy Services Limited Financial Results HCLTECH HCL Technologies Limited Corporate Action HCLTECH HCL Technologies Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when DIVISLAB files new disclosures

Track DIVISLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.